ClinicalTrials.gg
Status unknownNCT04714645Updated May 10, 2022

Effectiveness of Virtual Reality Training on Unilateral Spatial Neglect After Stroke

An interventional study of VR neglect training and VR control training in Stroke and Neglect, sponsored by Vrije Universiteit Brussel. Status unknown at 1 site in Belgium. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2022-05-10.

Sponsored by Vrije Universiteit Brussel · Not applicable, Interventional, and Treatment

The sponsor has not verified this record recently (last verified May 2022), so the status shown — last known as Active, not recruiting — may be out of date.
Phase
Not applicable
Study type
Interventional
Enrollment
40
Allocation
Randomized
Ages
18 Years and older
Sex
All
01

Study summary

The aim of this study is to examine the effect of an additional VR training program on unilateral spatial neglect (USN) after stroke. Principally, clinical assessment of the presence of unilateral spatial neglect and additionally the severity of USN will be measured using the Behavioral Inattention test (BIT), using only the BIT Conventional subtest (BITC). Secondarily, the VR outcomes will be included as well.

Finally, we want to determine if the effects last over a short period of time. It is important to know whether the potential effects of the VR-training remain without continuing the intervention. Therefore, we will perform a follow-up assessment after 1 week.

Read the detailed description

STUDY DESIGN

The design of this study is a 1-week, assessor-blinded randomized controlled trial with a 1-week follow up.

MATERIALS

The HMD VR system 'Oculus Rift' (Oculus, LLS, US) is a low-cost HMD that fully integrates the user into the virtual environment by blocking out perception of the real-world. It includes a headset, two oculus touch controllers and two sensors. To power the Oculus Rift, a compatible laptop will be used. The "Oculus Rift" will assure a fully immersive virtual environment.

PROCEDURE

Pre-treatment assessment: First, eligible patients will be screened and assessed. For screening and assessment, patients will undergo 2 tests: a VR test and a conventional test. The patient will be seated in a (wheel)chair while performing the assessment tests, with one of the researchers present for safety. All patients will immediately complete the tests, without a try-out session. Instructions will be given in a consistent way and during the tests no feedback will be given.

For the VR-test, the HMD will be used. The VR test consists of 5 different tasks:

  1. penguin search (1min)
  2. smartphone search (1min)
  3. apple examination (12 apples)
  4. penguin extinction (10 times)
  5. grabbing cubes (6 cubes)

For the conventional test, patients will need to perform the Behavioral Inattention test - conventional subtest (BITC), which consists of 6 different tasks:

  1. line crossing
  2. letter cancellation
  3. star cancellation
  4. figure and shape copying
  5. line bisection
  6. representational drawing

Once the assessment is completed, all patients will receive a standard care program provided by the rehabilitation hospital.

Intervention group:

Additionally, the intervention group will receive a VR training for 30 min consisting of various specific developed tasks for unilateral neglect training for a period of five consecutive days (one session a day). The VR training consists of the same 5 tasks used for the assessment. On the last day of the intervention and one week after, patients will be assessed again by completing the BITC test and the VR tasks.

Task 1: Penguin search: the patient has to search a penguin, which is randomly placed in the virtual environment. The patient has to aim for the penguin with this crosshair for a certain amount of time (until the loading bar is filled) in order to receive a point. The penguin is teleported to a new position afterwards. The subject has 2 minutes to gain as many points as possible. When the patient is not able to locate the penguin, arrows will indicate the direction of the penguin.

Task 2: Smartphone search: The Smartphone Search task is similar to the Penguin Search task. This time it takes place in a kitchen and the subject has to search for a smartphone on the kitchen counter. This kitchen counter is located in front of the subject. As in task 1, a crosshair is placed in the center of the camera canvas and the player receives points by aiming at the target. Like before, the subject has 2 minutes to gain as many points as possible. Like in the previous task, some arrows show up after ten seconds to help the subjects when they are not able to find the smartphone.

Task 3: Apple examination: In the Apple Examination task, the patient has to distinguish normal apples from distractors. The subject is placed in a grass landscape with 8 normal apples and 12 distractors. As in the previous tasks, a crosshair is attached to the canvas of the camera. The subject has to aim for the normal apples and press button A or X of the oculus controllers to get a point. The task ends when all normal apples are found.

Task 4: Penguin extinction: This task takes place in the same mountain environment as the Penguin Search task. In contrast with the other tasks, the subject doesn't have to search in the virtual environment, since everything takes place in the subject's field of view. There are three scenario's: either there is one penguin present on the right side, either there is one present on the left, or two penguins are present, one on each side. The subject has to say which scenario was presented by moving the thumbstick of the right or left oculus controller accordingly to the right (correct answer for scenario 1), to the left (correct answer for scenario 2) or upwards (correct answer for scenario 3). A point is gained for every correct answer. The task is completed when the subject has reached a score of thirty.

Task 5: Grabbing cubes: The last task is called Grabbing Cubes. Ten cubes are randomly placed on a table which is located in front of the player. The subjects have to grab the cubes and remove them from the table by dropping them on the ground. Grabbing an object is done by pressing the hand trigger of the left or right oculus controller. In order to complete the task, they have to remove all the cubes from the table.

Control group:

The control group will receive a placebo VR intervention. Patients in the control group will also use the HMD but they will look at another virtual environment with no specific tasks. The virtual environment represents a park outside where other avatars (hikers, joggers) are passing by. Patients will be looking at the environment for the same time as the VR training of the intervention group, i.e. 1 session a day for 5 days. On the last day of the intervention and one week after, patients will be assessed again by completing the BITC test and the VR tasks.

RANDOMIZATION

Participants will be randomly allocated to either the intervention group or the control group (1:1 ratio). Patients will be assigned to a group by block randomization.

STUDY ANALYSIS

Since heterogeneity between groups will be present at baseline, an ANCOVA analysis will be conducted to correct this matter. If significant changes are found at postintervention and follow-up, post-hoc analyses for multiple comparisons will be performed using the Bonferroni correction.

02

Conditions studied

  • Stroke
  • Neglect

Browse trials for

Keywords

  • virtual reality
  • neglect
  • stroke
  • intervention
03

In context

Stroke

7,441 studies on the registry are indexed under Stroke; 2,012 are open to participants now.

This study's planned enrollment of 40 is below the median of 50 across 5,482 interventional studies indexed under Stroke.

Browse Stroke studies →

Lead sponsor

Vrije Universiteit Brussel is the lead sponsor of 157 studies on the registry; 44 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • a right-hemisphere hemorrhagic or ischemic stroke, confirmed by CT or MRI
  • only subacute (>2 weeks) and chronic (>6 months) unilateral spatial neglect patients
  • scoring below the cut-off value of 129 points on the standard BITC test
  • being 18 years or older at the time of lesion

Exclusion criteria

Exclusion Criteria:

  • patients with dementia (Mini Mental State Examination (MMSE) \< 24) or aphasia (Mississippi Aphasia Screening Test (MAST) \< 45)
  • patients whose visual or hearing impairment does not allow possibility of interaction with the VR system
  • patients with depression (Patient Health Questionnaire (PHQ-9) >= 10)
  • patients unable to sit for at least 30 minutes in a wheelchair or chair
  • patients with sensorimotor alterations that can interfere with the performance with the VR system
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Outcomes assessor)
Enrollment
40 participants (estimated)

Study arms

  • Experimental
    Intervention group

    VR+ training

    Device: VR neglect training

  • Sham comparator
    Control group

    VR- training

    Device: VR control training

Interventions

  • DeviceVR neglect training

    Patients will undergo 1 session a day for 30 minutes for 5 consecutive days. The training consists of 5 different VR tasks specifically designed for neglect training.

  • DeviceVR control training

    Patients will undergo 1 session a day for 30 minutes for 5 consecutive days. This is a placebo training, where patients will also wear the HMD. Patients will be immersed in a virtual environment without a specific task.

06

What researchers measure

Primary outcomes

  1. BITC test

    The BITC test will be taken before, immediately after and 1-week after the intervention.

    Time frame: through study completion, i.e. 12 days

Secondary outcomes

  1. VR specific outcome: head rotations

    The head rotations (left/right) will be recorded continuously during the VR tasks. The head rotations made during the VR tasks before, immediately after and 1-week after the intervention will be compared

    Time frame: through study completion, i.e. 12 days

  2. VR specific outcome: time

    The time needed to complete the different VR tasks will be recorded. The time needed to complete the VR tasks before, immediately after and 1-week after the intervention will be compared.

    Time frame: through study completion, i.e. 12 days

  3. VR specific outcome: number of errors

    The number of errors made by the patient during the different VR tasks will be recorded. The number of errors made during the VR tasks before, immediately after and 1-week after the intervention will be compared.

    Time frame: through study completion, i.e. 12 days

07

Study locations

1 site
  • Vrije Universiteit Brussel
    Brussels, 1050, Belgium
08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on May 10, 2022, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT04714645
Responsible party
Emma De Keersmaecker (Principal Investigator, Vrije Universiteit Brussel) — Principal investigator
First posted
Jan 19, 2021
Start date
Feb 15, 2021
Primary completion
Dec 31, 2022 (estimated)
Completion
Dec 31, 2022 (estimated)
Last update
May 10, 2022

Study contacts

Eva Swinnen, Prof. Ph.D
principal investigator · Vrije Universiteit Brussel

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is status unknown, as verified in May 2022. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion